| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| (±)-PPHT.HCl | (±)-2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin hydrochloride |
| 6-OHDA | 6-hydroxydopamine |
| AChE | Acetylcholinesterase |
| AR | Adenosine receptor |
| AI | Artificial intelligence |
| BDNF | Brain-derived neurotrophic factor |
| cAMP | Cyclic adenosine monophosphate |
| K i | Dissociation constant |
| DR | Dopamine receptor |
| GDNF | Glial cell line-derived neurotrophic factor |
| EC50 | Half maximal effective concentration |
| IC50 | Half maximal inhibitory concentration |
| H3R | Histamine H3 receptor |
| iPSC | Induced pluripotent stem cells |
| LRRK2 | Leucine-rich repeat kinase 2 |
| MAO | Monoamine oxidase |
| MAO-B | Monoamine oxidase B |
| MAPT | Microtubule-associated protein tau |
| NGF | Nerve growth factor |
| NO | Nitric oxide |
| NOR | Nociceptin opioid receptor |
| NP | Network pharmacology |
| NSCs | Neural stem cells |
| NSE | Neuron-specific enolase |
| PD | Parkinson’s disease |
| PDE4 | Phosphodiesterase-4 |
| QSAR | Quantitative structure-activity relationship |
| SI | Selectivity index |
| SAR | Structure-activity relationship |
| SVZ | Subventricular zone |
| SN | Substantia nigra |
| SVM | Support vector machine models |
| SYN | Synpatophysin protein |
| THT | Thioflavin T |
| TH | Tyrosine hydroxylase |